CalciMedica Inc CALC

Healthcare Biotechnology

CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora, a potent and selective intravenous (IV) formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The Company is conducting a Phase 2b trial (called CARPO - NCT04681066) for acute pancreatitis (AP) with systemic inflammatory response syndrome (SIRS), as well as supporting the ongoing Phase 1/2 asparaginase induced pancreatic toxicity (AIPT) study (called CRSPA - NCT04195347).

NDAQ:CALC - Post by User

CalciMedica Inc

<< Previous

Bullboard Posts

Next >>

Post by alphaflighton Feb 01, 2022 10:49pm

375 Views

Post# 34387845

Join James Macintosh, CEO of Graycliff for a Webinar

Join James Macintosh, CEO of Graycliff Exploration, for a Webinar with Taylor Combaluzier, RedCloud's Mining Analyst

Live Presentation and Q&A on February 17, 2022 at 2 pm EST

REGISTER HERE:

https://redcloudfs.com/rcwebinar-gray-2/

About Graycliff Exploration Limited

Graycliff Exploration is a mineral exploration company focused on its 1,025 hectares of prospective ground, located roughly 80 kilometres west of Sudbury on the prolific Canadian Shield. The Company's past-producing Shakespeare Project is currently being drilled, with over 7,000 metres of drilling already completed and an extended mineralized zone open all directions with significant-width gold intersections reported. Graycliff’s Baldwin Project is adjacent to the east and geologically similar to Shakespeare, setting the scene for the makings of a new Ontario gold camp.